会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Substituted N-methylene derivatives of thienamycin
    • 噻吩霉素的取代的N-亚甲基衍生物
    • US4311704A
    • 1982-01-19
    • US159573
    • 1980-06-16
    • Burton G. ChristensenWilliam J. LeanzaDavid H. ShihKenneth J. Wildonger
    • Burton G. ChristensenWilliam J. LeanzaDavid H. ShihKenneth J. Wildonger
    • C07D477/20C07D487/04A61K31/40A61K31/425A61K31/44
    • C07D477/20
    • Disclosed are substituted N-methylene derivatives of thienamycin having the formula: ##STR1## wherein: (1.) X.dbd.--NR.sup.1 R.sup.2, and Y.dbd.--R'--N.dbd.CRNR.sup.1 R.sup.2, and(2.) X.dbd.R, and Y.dbd.--NR.sup.1 R'N.dbd.CRNR.sup.1 R.sup.2 ; andwherein: R is, inter alia, hydrogen, NH.sub.2, --NHR.sup.1, --NR.sup.1 R.sup.2, R.sup.1 and R.sup.2 ; R.sup.1 and R.sup.2 are independently selected from: hydrogen, substituted, or unsubstituted: alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heterocyclyl, and heterocyclylalkyl; R' is --(CH.sub.2).sub.n.sup.-, n is 1-6, or --(CH.sub.2).sub.m --Q--(CH.sub.2).sub.p.sup.-, m, n.dbd.1-3 and Q is O, S or R' is a carbocyclic or heterocyclic ring. Such compounds and their pharmaceutically acceptable salt, ether, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds, pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了具有下式的噻吩霉素的取代的N-亚甲基衍生物:其中:(1)X = -NR 1 R 2,Y = -R'-N = CRNR 1 R 2,和(2)X = R,Y = -NR1R'N = CRNR1R2; 并且其中:R特别是氢,NH 2,-NHR 1,-NR 1 R 2,R 1和R 2; R 1和R 2独立地选自:氢,取代或未取代的:烷基,烯基,炔基,环烷基,环烷基烷基,芳基,芳烷基,杂芳基,杂芳烷基,杂环基和杂环基烷基; R'为 - (CH 2)n - ,n为1-6或 - (CH 2)m Q-(CH 2)p - ,m,n = 1-3,Q为O,S或R'为碳环或杂环 环。 这些化合物及其药学上可接受的盐,醚,酯和酰胺衍生物可用作抗生素。 还公开了制备这些化合物的方法,包含这些化合物的药物组合物; 和治疗方法,包括当指出抗生素效应时施用这些化合物和组合物。
    • 5. 发明授权
    • N-heterocyclic derivatives of thienamycin
    • 噻吩霉素的N-杂环衍生物
    • US4189493A
    • 1980-02-19
    • US865283
    • 1977-12-28
    • Burton G. ChristensenJohn HannahDavid H. Shih
    • Burton G. ChristensenJohn HannahDavid H. Shih
    • C07D477/20C07D403/12
    • C07D477/20
    • Disclosed are N-derivatives of thienamycin having structures I and II. ##STR1## wherein: the bifunctional radical may contain additional unsaturation in the ring; and wherein n is an integer selected from 1-6; p is 0, 1 or 2; R.sup.1 is selected from hydrogen, alkyl having 1-6 carbon atoms, and aryl having 6-10 carbon atoms; and Z is imino (.dbd.NH), oxo (.dbd.O), hydrogen, amino, or alkyl having 1-6 carbon atoms. Such compounds and their pharmaceutically acceptable salt and ester derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds pharmaceutical compositions comprising such compounds and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了具有结构I和II的噻吩霉素的N-衍生物。 其中:双官能团可以在环中含有额外的不饱和键; 并且其中n是选自1-6的整数; p为0,1或2; R1选自氢,具有1-6个碳原子的烷基和具有6-10个碳原子的芳基; 和Z是亚氨基(= NH),氧代(= O),氢,氨基或具有1-6个碳原子的烷基。 这些化合物及其药学上可接受的盐和酯衍生物可用作抗生素。 还公开了制备这种化合物的方法,包含这些化合物的药物组合物和治疗方法,包括当指示抗生素效果时施用这些化合物和组合物。
    • 6. 发明授权
    • 6-(1-hydroxyethyl)-2-carbamimidoyl-pen-2-em-3-carboxylic acids
    • 6-(1-羟基乙基)-2-氨甲脒基 - 二氧戊环-3-羧酸
    • US4650794A
    • 1987-03-17
    • US373088
    • 1982-04-29
    • Burton G. ChristensenFrank P. DiNinnoWilliam J. LeanzaRonald W. Ratcliffe
    • Burton G. ChristensenFrank P. DiNinnoWilliam J. LeanzaRonald W. Ratcliffe
    • C07D499/88C07D499/00A61K31/425
    • C07D499/88
    • Disclosed are 6-(1-hydroxyethyl)-2-carbamimidoyl-pen-2-em-3-carboxylic acids (I) having the representative structure: ##STR1## wherein: A is a direct, single bond connecting the indicated S and C atoms, or A is a cyclic or acyclic connecting group selected, inter alia, from alkyl, cycloalkyl, aryl, heteroaryl, heteroalkyl; R.sup.1 and R.sup.2, which define the carbamimidoyl function, are, inter alia, independently selected from hydrogen, alkyl, aryl, alkoxy, amino; additionally, said carbamimidoyl is characterized by cyclic structures achieved by the joinder of the two nitrogen atoms via their substituents and by their joinder to connecting group A; additionally, "carbamimidiums" are disclosed by quaternization of one of the nitrogen atoms of said carbamimidoyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharmaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.
    • 公开了具有以下代表性结构的6-(1-羟基乙基)-2-氨基甲脒基 - 二-2-甲基-3-羧酸(I):其中:A是连接所指示的S和 C原子或A是环状或无环连接基团,特别是选自烷基,环烷基,芳基,杂芳基,杂烷基; 定义氨基甲酰基官能团的R 1和R 2尤其独立地选自氢,烷基,芳基,烷氧基,氨基; 另外,所述的氨基甲脒基的特征在于通过两个氮原子通过它们的取代基并通过它们与连接基团A的连接而实现的环状结构; 此外,“氨基甲酰胺”通过所述氨甲脒基的氮原子之一的季铵化来公开。 这些化合物及其药学上可接受的盐,酯和酰胺衍生物可用作抗生素。 还公开了制备这些化合物的方法; 包含这些化合物的药物组合物; 和治疗方法,包括当指出抗生素效应时施用这些化合物和组合物。